Insider Selling: OrthoPediatrics Corp. (NASDAQ:KIDS) Insider Sells 5,359 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) insider Gregory A. Odle sold 5,359 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the sale, the insider now owns 148,788 shares in the company, valued at $3,698,869.68. This trade represents a 3.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

OrthoPediatrics Stock Down 2.2 %

Shares of NASDAQ KIDS traded down $0.57 during midday trading on Friday, reaching $24.97. The company's stock had a trading volume of 299,893 shares, compared to its average volume of 162,897. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. OrthoPediatrics Corp. has a fifty-two week low of $21.02 and a fifty-two week high of $35.99. The stock has a market capitalization of $606.45 million, a price-to-earnings ratio of -20.30 and a beta of 1.22. The stock has a 50 day simple moving average of $24.85 and a 200-day simple moving average of $25.48.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same period last year, the company earned ($0.23) earnings per share. Equities research analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Remove Ads

Hedge Funds Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently made changes to their positions in the company. Quarry LP bought a new position in shares of OrthoPediatrics in the third quarter valued at $25,000. R Squared Ltd bought a new position in shares of OrthoPediatrics in the fourth quarter valued at $48,000. KLP Kapitalforvaltning AS bought a new position in shares of OrthoPediatrics in the fourth quarter valued at $79,000. BNP Paribas Financial Markets grew its stake in shares of OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock valued at $94,000 after buying an additional 1,929 shares in the last quarter. Finally, Quantbot Technologies LP grew its stake in shares of OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company's stock valued at $157,000 after buying an additional 1,712 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

KIDS has been the topic of several research analyst reports. Stifel Nicolaus dropped their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a report on Wednesday, March 5th. Needham & Company LLC restated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th. Finally, Truist Financial dropped their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating on the stock in a report on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.